ImmusanT start-up raises $20m to advance therapeutic vaccine for coeliac disease
15 December 2011
Nancy Faigen
Please Login to read the full article.
15 December 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Verastem takes a shot at tough public market, files for $50M IPO
- US Capitol Capsule: Obama pushes for crowdfunding, while SEC panel cautious
- Tokai raises $23M Series D from Novartis, Apple Tree for triple approach to prostate cancer
- Tensha banks $15M Series A to develop bromodomain inhibitor epigenetic drugs
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
